Page 4131
Jun 8, 2022
Rectal Cancer Disappears After Experimental Use of Immunotherapy
Posted by Omuterema Akhahenda in category: biotech/medical
Sascha Roth remembers the phone call came on a hectic Friday evening.
She was racing around her home in Washington, D.C., to pack for New York, where she was scheduled to undergo weeks of radiation therapy for rectal cancer. But the phone call from Memorial Sloan Kettering Cancer Center (MSK) medical oncologist Andrea Cercek changed everything, leaving Sascha “stunned and ecstatic — I was so happy.”
Continue reading “Rectal Cancer Disappears After Experimental Use of Immunotherapy” »
Jun 8, 2022
Gwynne Shotwell, President and COO of SpaceX
Posted by Chris J. Kent in category: space travel
“Aim high. We have always achieved what we wanted to, never in the timeline. We fail on timeline, but that feels like the right fail to make as oppose to not achieving what you are trying to achieve technically.”
In this View From The Top, Christopher Stromeyer, MBA ’22, sits down with Gwynne Shotwell, President and COO of SpaceX, to discuss balancing ambitious goals, putting people on Mars in a decade, leading collaboratively, and why she likes making decisions with data.
Continue reading “Gwynne Shotwell, President and COO of SpaceX” »
Jun 8, 2022
A breakthrough drug trial astonished doctors
Posted by Gemechu Taye in categories: biotech/medical, innovation
Jun 8, 2022
High-Rise Piggeries: What China’s Pork Industry Transformation Means to U.S. Farmers
Posted by Gemechu Taye in categories: food, sustainability
Jun 8, 2022
Traditional toolmaker turns to Vtex to help it on its digitalisation journey
Posted by Shubham Ghosh Roy in category: futurism
The 179-year-old tool company Stanley Black & Decker is becoming a model e-commerce player, as global digital enterprise Vtex has helped it transform its digital offering to stay ahead of the game.
Jun 8, 2022
Ingenuity has Lost its Sense of Direction, but It’ll Keep on Flying
Posted by Alberto Lao in categories: computing, information science, space
The Ingenuity chopper on Mars has lost an instrument that helps it navigate. Flight controllers have found a work-around.
Things are getting challenging for the Ingenuity helicopter on Mars. The latest news from Håvard Grip, its chief pilot, is that the “Little Chopper that Could” has lost its sense of direction thanks to a failed instrument. Never mind that it was designed to make only a few flights, mostly in Mars spring. Or that it’s having a hard time staying warm now that winter is coming. Now, one of its navigation sensors, called an inclinometer, has stopped working. It’s not the end of the world, though. “A nonworking navigation sensor sounds like a big deal – and it is – but it’s not necessarily an end to our flying at Mars,” Grip wrote on the Mars Helicopter blog on June 6. It turns out that the controllers have options.
Like other NASA planetary missions, Ingenuity sports a fair amount of redundancy in its systems. It has an inertial measurement unit (IMU) that measures accelerations and angular rates of ascent and descent in three directions. In addition, there’s a laser rangefinder that measures the distance to the ground. Finally, the chopper has a navigation camera. It gives visual evidence of where Ingenuity is during flight or on the ground. An algorithm takes data from these instruments and uses it during flight. But, it needs to know the chopper’s roll and pitch attitude, and that’s what the inclinometer supplies.
Continue reading “Ingenuity has Lost its Sense of Direction, but It’ll Keep on Flying” »
Jun 8, 2022
Cellular secrets unlocked by researchers lead to new theory for aging
Posted by Kelvin Dafiaghor in categories: biotech/medical, genetics, life extension
New research has uncovered how genetic changes that accumulate slowly in blood stem cells throughout life are likely to be responsible for the dramatic change in blood production after the age of 70.
The study, by scientists at the Wellcome Sanger Institute, the Wellcome-MRC Cambridge Stem Cell Institute and collaborators, has been published in the journal Nature.
Longevity. Technology: Has our understanding of one of the mechanisms of aging taken a quantum leap? Molecular damage accumulates throughout our lives, gradually increasing year-on-year as we suffer telomere attrition, mutation, epigenetic change and oxidative and replicative stress. It’s a double whammy as our ability to repair this damage also declines as we age, but given the gradual nature of these processes, why, as the paper authors themselves put it, “Is there an abrupt increase in mortality after 70 years of age? [1]”.
we will be bringing you extracts from 9 trailblazer profiles from our new Neurotech report – dynamic and innovative companies we feel are driving this exciting space. Each profile includes a flagship product deep dive which offers a forensic consideration of product development, efficacy, target market, channels to market, success factors, IP and funding.
AE was born of the vision to increase human agency for end users through the technology the group develops for their partners and their wholly-owned and operated skunkworks companies. Running a highly collaborative agile process, these efforts are extended by investing heavily in the brain computer interface (BCI) space. BCI represents, to AE, the pinnacle of agency increasing tech with massive implications for users and the whole of humanity.
Jun 8, 2022
New CRISPR Tool Protects Against Viruses Without Making Any DNA Cuts
Posted by Kelvin Dafiaghor in category: biotech/medical
A study published last week in Molecular Cell took a step towards that radical new concept for CRISPR. Led by Dr. Jennifer Doudna at the University of California Berkeley, who shared a Nobel Prize as a pioneer in the field, the study honed in on Cas9’s less famous and far more enigmatic cousin, Cas12c.
It’s the black sheep of the Cas family. Unlike other members, Cas12c completely lacks the ability to cut DNA. Instead, in bacteria cells, it binds onto invading viruses and protects vulnerable cells without shredding the virus’s DNA. The end result is a powerful antiviral defense system that doesn’t tax the host cell’s inner workings—yet makes it invincible to certain viral infections.
The study shows that chopping up viral DNA isn’t the only route for antiviral defense, at least in bacteria cells, the authors said. But more importantly, we’ve only begun scratching the surface of CRISPR gene editors.
